Cardiovascular Outcomes with GLP-1 Receptor Agonists in Patients with Diabetes or Obesity Undergoing Transcatheter Aortic Valve Replacement

By afschroeder • April 23, 2026

Goyal A, Saeed H, Jain H, Hurjkaliani S, Mahalwar G, Jaiswal V, Ricciardi MJ, Kolte D, Fonarow GC, Piazza G, Kapadia S, Qamar A. Cardiovascular Outcomes with GLP-1 Receptor Agonists in Patients with Diabetes or Obesity Undergoing Transcatheter Aortic Valve Replacement. Can J Cardiol. 2026 Apr 20:S0828-282X(26)00358-2. doi: 10.1016/j.cjca.2026.04.003. Epub ahead of print. PMID: 42019817.

Tags: Cardiology/Epi, glp-1 ra, mortality, Outcomes, Publications, Structural, TAVR, transcatheter aortic valve replacement

High agreement of coronary artery calcification scores between full-dose (6.5 mSv) and reduced-dose (1.5 mSv) chest computed tomography: A retrospective analysis of COPDGene

Moore JM, Pratte KA, Ferguson C, Casaburi R, Iskander B, Abbasi A, Alapati P, Chilukuri S, Narashim A, Budoff MJ, Rossiter HB. High agreement of[...]

Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) maintains muscle progenitor identity by stabilizing the Ppp1r1b-lncRNA-PRC2 complex

Kang X, Zhao Y, Nelson SF, Pyle A, Lusis AJ, Touma M. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) maintains muscle progenitor identity by stabilizing the Ppp1r1b-lncRNA-PRC2[...]

Outcomes of Early Sodium-Glucose Cotransporter 2 Inhibitor Use in Takotsubo Syndrome: Insights from a Multicenter Real-World Cohort Study

Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early[...]